The impact of dexamethasone as a perineural additive to ropivacaine for PECS II blockade in patients undergoing unilateral radical mastectomy – A prospective, randomized, controlled and double-blinded trialElisabeth Hoerner, Guenther Putz, Lukas Gasteiger et al.|Journal of Clinical Anesthesia|2021Cited by 15
Neoadjuvant atezolizumab in combination with dual HER2 blockade plus epirubicin in women with early HER2-positive breast cancer: the randomized phase 2 ABCSG-52/ATHENE trialGabriel Rinnerthaler, Richard Greil, Edgar Petru et al.|Nature Cancer|2025Cited by 10
Prospective randomized phase II trial to assess the efficacy and safety of neo-adjuvant olaparib/carboplatin (OC) in comparison to docetaxel/epirubicin/cyclophosphamide (TAC) in patients with early triple-negative breast cancer (TNBC) with homologous recombination deficiency (HRD): Primary results from the ABCSG 45 trial.Christian F. Singer, Michael Gnant, Dominik Hlauschek et al.|Journal of Clinical Oncology|2025Cited by 3